"Debate - The use of cardiac biomarkers in risk stratification" Clinical Chemistry and Laboratory Medicine (CCLM), vol. 61, no. s1, 2023, pp. s29-s30. https://doi.org/10.1515/cclm-2023-7012
(2023). Debate - The use of cardiac biomarkers in risk stratification. Clinical Chemistry and Laboratory Medicine (CCLM), 61(s1), s29-s30. https://doi.org/10.1515/cclm-2023-7012
(2023) Debate - The use of cardiac biomarkers in risk stratification. Clinical Chemistry and Laboratory Medicine (CCLM), Vol. 61 (Issue s1), pp. s29-s30. https://doi.org/10.1515/cclm-2023-7012
"Debate - The use of cardiac biomarkers in risk stratification" Clinical Chemistry and Laboratory Medicine (CCLM) 61, no. s1 (2023): s29-s30. https://doi.org/10.1515/cclm-2023-7012
Debate - The use of cardiac biomarkers in risk stratification. Clinical Chemistry and Laboratory Medicine (CCLM). 2023;61(s1): s29-s30. https://doi.org/10.1515/cclm-2023-7012